Mitchel L. Zoler, PhD
News
Heart failure readmission penalties linked with rise in deaths
November 18, 2017
Heart failure readmissions penalties linked with rise in deaths ANAHEIM, CALIF. – Evidence continues to mount that Medicare’s penalization of hospitals with excess heart failure readmissions has cut readmissions but at the apparent price of more deaths.During the penalty phase of...
![1]()
News
Prescribers mostly ignore clopidogrel pharmacogenomic profiling
November 16, 2017
ANAHEIM, CALIF. – Physicians treating ACS patients with an antiplatelet all but ignore their genetically assessed ability to metabolize clopidogrel.
![1]()
Video
VIDEO: U.S. hypertension guidelines reset threshold to 130/80 mm Hg
November 14, 2017
ANAHEIM, CALIF. – Thirty million Americans became hypertensive overnight.
![1]()
News
VIDEO: Balanced crystalloids protect kidney better than saline
November 1, 2017
TORONTO – Vanderbilt University Medical Center is transitioning from primarily using saline to balanced crystalloid IV fluids to prevent adverse renal events in hospitalized patients.
![1]()
News
MI, stroke risk from HFrEF surpasses HFpEF
October 17, 2017
DALLAS – Events go up as ejection fraction declines.
Video
VIDEO: Intermittent furosemide during acute HFpEF favors kidneys
October 12, 2017
DALLAS – Bolus treatment cut creatinine increases by two-thirds.
![1]()
News
LVAD use soars in elderly Americans
October 3, 2017
DALLAS – As the use of left ventricular assist devices skyrocketed, so did short-term survival.
![1]()
News
While U.S. heart failure readmissions fall, deaths rise
September 20, 2017
DALLAS – CMS’s penalties for heart failure outcomes may have unintentionally pushed hospitals toward “gaming the system.”
![1]()
News
VIDEO: Educational intervention boosts A fib anticoagulation
September 19, 2017
BARCELONA – Patient education and feedback increased anticoagulation and cut strokes.
![1]()
Video
VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients
August 28, 2017
BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,” commented Eugene Braunwald, MD.
